These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38591664)

  • 21. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah V; Ohlsson A; Halliday HL; Dunn MS
    Cochrane Database Syst Rev; 2000; (2):CD001969. PubMed ID: 10796275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Walker E; Osborn DA
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants.
    Shah P; Ohlsson A
    Cochrane Database Syst Rev; 2001; 2001(3):CD002775. PubMed ID: 11687026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
    Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
    Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.
    Albertella M; Gentyala RR; Paraskevas T; Ehret D; Bruschettini M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013232. PubMed ID: 37811631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal high flow therapy for primary respiratory support in preterm infants.
    Hodgson KA; Wilkinson D; De Paoli AG; Manley BJ
    Cochrane Database Syst Rev; 2023 May; 5(5):CD006405. PubMed ID: 37144837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants.
    Romantsik O; Smit E; Odd DE; Bruschettini M
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD001691. PubMed ID: 36924438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001146. PubMed ID: 19160190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
    Moresco L; Sjögren A; Marques KA; Soll R; Bruschettini M
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015462. PubMed ID: 37791592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
    Subramaniam P; Ho JJ; Davis PG
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
    Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.
    Lemyre B; Deguise MO; Benson P; Kirpalani H; Ekhaguere OA; Davis PG
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD005384. PubMed ID: 37466143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylxanthine for the prevention and treatment of apnea in preterm infants.
    Marques KA; Bruschettini M; Roehr CC; Davis PG; Fiander M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013830. PubMed ID: 37905735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.
    Walters A; McKinlay C; Middleton P; Harding JE; Crowther CA
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD003935. PubMed ID: 35377461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001144. PubMed ID: 12535400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.